Please login to the form below

Not currently logged in
Email:
Password:

EMA/FDA extend confidentiality arrangements

The European Medicines Agency and US Food and Drug Administration have extended shared confidentiality arrangements indefinitely

The European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have extended shared confidentiality arrangements indefinitely.

The arrangements between the regulatory bodies cover issues related to medicinal products for human and veterinary use, with an initial deal signed in 2003. This has now been extended with no need for further renewal according to a statement from the EMA.

The deal allows both organisations to share confidential information as part of their individual regulatory and scientific processes.

According to the EMA, the aim of the arrangements is "to promote public and animal health and to protect European and US patients."

Specific types of information to be shared by the company, as stated in the original 2003 agreement, include:

• Good Clinical Practice inspection reports of clinical trial sites
• Drafts of pending laws, regulations and guidance documents
• Post-marketing data and information that could impact public health
• Information on defects or recalls known by one agency to have been manufactured or distributed in the other agency's territory

The new agreement will see its current implementations remain valid.

16th September 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics